<DOC>
	<DOCNO>NCT02044029</DOCNO>
	<brief_summary>This non-drug , single center , 24-week , longitudinal study ambulant spinal muscular atrophy ( SMA ) patient age- gender-matched healthy volunteer assess detection disease progression magnetic resonance imaging ( MRI ) Muscle Function Measure ( MFM ) test . Each participant evaluate three test session : baseline , Week 12 Week 24 . Both patient volunteer undergo MRI scan . Patients additionally undergo test motor function blood sample take Survival Motor Neuron ( SMN ) gene , protein mRNA analysis .</brief_summary>
	<brief_title>Ability Muscle Imaging Motor Function Measure ( MFM ) Detect Changes Disease Progression Ambulant Spinal Muscular Atrophy Patients Compared Healthy Volunteers .</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<criteria>Male female subject , age &gt; /= 10 year screen For SMA patient : Confirmed clinical diagnosis 5qautosomal recessive SMA , ambulant time screening , prefereably without spinal cord fixation Previous ( 3 month less ) concomitant participation therapeutic trial Known suspect cancer Other chronic disease inadequate renal , liver , heart function Contraindications MRI scan , include limited : claustrophobia , pacemaker , artifical heart valve , cochlear implant , presence foreign metal object body , intracranial vascular clip , etc . Any contraindication MRI find standard radiography scan .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>